Either of the potential solutions (dose reduce or switch to an alternative TKI) is possible. Depending on the specific intolerance, it would be reasonable to try a dose reduction. If the patient still cannot tolerate the imatinib and the patient is a high risk, then sunitinib may be better tolerated...